20 May 2013
Keywords: virexx, completes, 12m, financing, canada, medical, company
Article | 20 February 2006
Canada's ViRexx Medical, a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B and C and embolotherapy
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 February 2006
13 February 2006
© 2013 thepharmaletter.com